Journal
NEUROLOGY
Volume 67, Issue 11, Pages 2045-2047Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000247278.88077.09
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 NS002984-09] Funding Source: Medline
Ask authors/readers for more resources
Fabry disease results in a global vasculopathy leading to earlyonset stroke and renal and cardiac failure. We found that random myeloperoxidase in serum and plasma was significantly elevated in 73 consecutive male patients with Fabry disease. Random serum myeloperoxidase level in men predicted the risk of a Fabry vasculopathy-related event in subsequent years. Long-term enzyme replacement therapy did not reduce myeloperoxidase level or eliminate the risk of vasculopathic events.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available